跳至主要内容
临床试验/NCT01783795
NCT01783795已完成不适用

Screening for Dent Disease Mutations in Patients With Proteinuria

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2012年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
180
试验地点
2
主要终点
Number of subjects with genetic mutations in either the CLCN5 or ORCL1 gene

研究概览

简要总结

This study will help the investigator determine whether certain genetic mutations, more than others, are a cause of more severe disease in Dent Disease.

详细描述

During this study visit, the investigator will draw one tube, about two teaspoonfuls (1 to 1 ½ teaspoons for children), of blood from the subject's arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing. The investigator will use the isolated DNA to try to identify the gene that is defective in Dent Disease by comparing it with the structure of genes in normal individuals, patients with Dent Disease, and family members for Dent Disease.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • The patient has been diagnosed, or in the process of being diagnosed with Dent Disease.
  • The patient has a family member diagnosed with Dent Disease.

排除标准

  • 未提供

结局指标

主要结局

Number of subjects with genetic mutations in either the CLCN5 or ORCL1 gene

时间窗: 4 years

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

John Lieske

M.D.

Mayo Clinic

研究点 (2)

Loading locations...

相似试验